Curious about the Mobilise-D Technical Validation Study, what we did, and what we found? We have created a lay summary of the study so we can share our work and findings with the public. The summary covers who was involved, what we did, what we found, and what we will do next. The document will…
The Mobilise-D consortium and the Critical Path Institute (C-Path) are thrilled to announce the signing of a collaboration agreement, which will be an important step forward in achieving lasting impact. C-Path is an independent nonprofit, public-private partnership with the U.S. Food and Drug Administration (FDA). C-Path orchestrates the development of actionable solutions through an innovative, collaborative…
Mobilise-D will present its hip fracture cohort on Wednesday, December 7. Regaining gait function after a hip fracture is key to recovery and one of the main aims of treatment and rehabilitation. Yet, many hip fracture patients fail to regain former levels of mobility and activity. What underlies recovery and how can we optimise it?…
In 2006, Clint Hansen (38) stumbled across gait analysis when he did an internship in the gait lab at Aschau working with patients with cerebral palsy. Ever since he has been hooked on human motion capture. Eleven years later, he started running the Neurogeriatrics group in Kiel together with Professor Walter Maetzler. In 2020, Clint…
We are excited to announce our strategic partnership with Cure Parkinson’s UK, working closely together to bring our research and clinical studies closer to patients and the public. We asked Helen Matthews, Deputy CEO of Cure Parkinson’s, to share with us her vision about the benefits of the research and clinical trials in Parkinson’s Disease,…
We start the autumn Mobilise-D Webinars series presenting the needs, technologies, protocols and patient perspectives for each of our four cohorts engaged in the Mobilise-D studies. The first webinar this autumn will outline the need for wearable sensors in patients with multiple sclerosis (MS) as an important tool for use in both clinical settings and…
We are three-and-a-half years into Mobilise-D, and what a journey we have had together! The results of the Technical Validation Study are excellent, while recruitment of participants in the Clinical Validation Study has passed well over 2000 and is getting close to 90% of our target. Data sharing solutions are underway, and future interactions with…
The work on algorithm development and technical validation has come to an end. We cannot believe it’s been three years already! The Mobilise-D webinar series on the Technical Validation Study (TVS) had its fifth and last session on April 9, 2022. In this session, we showed how the sum of every single contribution in WP2…
In 2011, Stefanie Studenski presented her data on the powerful prediction of slow gait speed as an independent risk factor for mortality. This landmark paper raised the awareness of almost all disciplines in medicine and allied healthcare professionals to measure gait speed and develop a different perspective on physical mobility. This paper is also part…
We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached their target number of included participants. They just reported that participant #140 has entered the Mobilise-D study, thereby completing their target for the COPD (Chronic…